Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a) Written informed consent prior to performing study procedures. Witnessed oral consent will be accepted in order to avoid paper handling. Written consent by patient or their family members will be obtained wherever applicable. b) Male or Female adult patient >=18 years and c) Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR in naso/oropharyngeal swabs or any other relevant specimen d) Asymptomatic / uncomplicated illness / mild pneumonia COVID-19 as defined by ICMR
Exclusion criteria
Exclusion criteria: a) Explicit non-willingness to be a part of the research study b) Patients with moderate/severe stages of COVID19 c) Participation in any other clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to progress to next stage of severity i.e., from asymptomatic/uncomplicated/mild pneumonia to moderate/severe stagesTimepoint: At 15 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical endpoints 1. Time to All-cause mortality at discharge 2. All-cause mortality at 28 days Measures of morbidity 1. Number of days lived with infection 2. Number of days lived with intensive care if the disease has progressed to severe infection from asymptomatic, mild, and moderate stages. 3. Measuring the symptoms using standard scores Patient reported outcome 1. Quality of life as assessed by WHO-QoL BREF 2. Anxiety as assessed by GAD scale Safety outcomesTimepoint: At Discharge | — |
Countries
India
Contacts
Government Yoga AND Naturopathy Medical College